![Malcolm L. McConville](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Malcolm L. McConville
Profile
Malcolm L.
McConville worked as a Development Director at AmpliPhi Biosciences Corp.
and as a Development Manager at Biocontrol Ltd.
(United Kingdom).
He holds a doctorate degree from The University of Reading and an undergraduate degree from the University of Cardiff.
Former positions of Malcolm L. McConville
Companies | Position | End |
---|---|---|
Biocontrol Ltd. (United Kingdom)
![]() Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Corporate Officer/Principal | - |
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Malcolm L. McConville
University of Cardiff | Undergraduate Degree |
The University of Reading | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Biocontrol Ltd. (United Kingdom)
![]() Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Malcolm L. McConville